<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) are aggressive rapidly growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> typified by a high c-myc expression resulting from t(8;14)(q24;q32), t(2;8)(p12;q24) or t(8;22)(q24;q11) translocations </plain></SENT>
<SENT sid="1" pm="."><plain>Alterations of the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor are also relatively frequent in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Several approaches have been adopted for detection of the p53 aberrations such as immunohistochemical analyses, immunoblotting, DNA sequencing, fluorescence in situ hybridization (FISH), and functional assays </plain></SENT>
<SENT sid="3" pm="."><plain>We used these methods to characterize the p53 mutation in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells of a 53-year-old male suffering from Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>By immunohistochemical analyses, we detected high levels of the p53 protein in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue </plain></SENT>
<SENT sid="5" pm="."><plain>Immunoblotting showed a higher molecular weight of the p53 protein overexpressed in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues than that of the standard p53 protein </plain></SENT>
<SENT sid="6" pm="."><plain>Similarly, the molecular weight of the PCR product prepared by amplification of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> p53 cDNA was higher than that of the standard p53 cDNA </plain></SENT>
<SENT sid="7" pm="."><plain>Functional analyses of separated alleles in yeast evidently revealed that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> p53 protein was transcriptionally non-functional </plain></SENT>
<SENT sid="8" pm="."><plain>The yeast colonies expressing this p53 variant possessed a unique phenotype in that they were red with many <z:e sem="disease" ids="C0043154" disease_type="Disease or Syndrome" abbrv="">white spots</z:e> on their surface </plain></SENT>
<SENT sid="9" pm="."><plain>Sequencing of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cDNA revealed a duplication of the 30 bp region of the p53 gene (g.12155_12184dup30) leading to a repeat of 10 amino acids (Pro-77 to Ala-86) in the p53 protein </plain></SENT>
<SENT sid="10" pm="."><plain>Further analyses showed that the mutation was unstable in yeast cells </plain></SENT>
<SENT sid="11" pm="."><plain>The FISH analyses did not confer loss of the p53-specific locus 17p13 </plain></SENT>
</text></document>